165 related articles for article (PubMed ID: 19805676)
1. Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society.
Moon HG; Han W; Noh DY
J Clin Oncol; 2009 Dec; 27(35):5899-905. PubMed ID: 19805676
[TBL] [Abstract][Full Text] [Related]
2. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.
Kwan ML; Chen WY; Kroenke CH; Weltzien EK; Beasley JM; Nechuta SJ; Poole EM; Lu W; Holmes MD; Quesenberry CP; Pierce JP; Shu XO; Caan BJ
Breast Cancer Res Treat; 2012 Apr; 132(2):729-39. PubMed ID: 22187127
[TBL] [Abstract][Full Text] [Related]
3. Impact of BMI for clinical outcomes in Japanese breast cancer patients.
Gondo N; Sawaki M; Hattori M; Yoshimura A; Kotani H; Adachi Y; Kataoka A; Sugino K; Mori M; Horisawa N; Terada M; Ozaki Y; Iwata H
Jpn J Clin Oncol; 2020 Mar; 50(3):230-240. PubMed ID: 31958129
[TBL] [Abstract][Full Text] [Related]
4. Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean Breast Cancer Society.
Moon HG; Han W; Noh DY
J Clin Oncol; 2010 Apr; 28(10):1692-9. PubMed ID: 20194848
[TBL] [Abstract][Full Text] [Related]
5. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
6. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Chung IY; Lee JW; Lee JS; Park YR; Min YH; Lee Y; Yoon TI; Sohn G; Lee SB; Kim J; Kim HJ; Ko BS; Son BH; Ahn SH
PLoS One; 2017; 12(3):e0170311. PubMed ID: 28248981
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.
Kim EK; Noh WC; Han W; Noh DY
World J Surg; 2011 Jun; 35(6):1244-53. PubMed ID: 21472372
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
9. The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.
Jung SY; Jeong J; Shin SH; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
BMC Cancer; 2010 Dec; 10():664. PubMed ID: 21126378
[TBL] [Abstract][Full Text] [Related]
10. Influence of body mass index on oncological outcomes in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Liu JY; Li YH; Liu ZW; Zhang ZL; Ye YL; Yao K; Jiang LJ; Han H; Qin ZK; Zhou FJ
Int J Urol; 2014 Feb; 21(2):136-42. PubMed ID: 23931096
[TBL] [Abstract][Full Text] [Related]
11. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
12. Extremes in body mass index affect overall survival in women with cervical cancer.
Clark LH; Jackson AL; Soo AE; Orrey DC; Gehrig PA; Kim KH
Gynecol Oncol; 2016 Jun; 141(3):497-500. PubMed ID: 27058838
[TBL] [Abstract][Full Text] [Related]
13. Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
Ewertz M; Gray KP; Regan MM; Ejlertsen B; Price KN; Thürlimann B; Bonnefoi H; Forbes JF; Paridaens RJ; Rabaglio M; Gelber RD; Colleoni M; Láng I; Smith IE; Coates AS; Goldhirsch A; Mouridsen HT
J Clin Oncol; 2012 Nov; 30(32):3967-75. PubMed ID: 23045588
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.
Kawai M; Tomotaki A; Miyata H; Iwamoto T; Niikura N; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Nakamura S; Tokuda Y
Cancer Med; 2016 Jun; 5(6):1328-40. PubMed ID: 26923549
[TBL] [Abstract][Full Text] [Related]
15. Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
Cantini L; Pistelli M; Merloni F; Fontana A; Bertolini I; De Angelis C; Bastianelli L; Della Mora A; Santinelli A; Savini A; Maccaroni E; Diodati L; Falcone A; Berardi R
Clin Breast Cancer; 2020 Feb; 20(1):e89-e98. PubMed ID: 31378534
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective study in Chinese population.
Zhang X; Li P; Ma W; Di W; Zhao S; Gao Q; Zhao Y; Yang M; Zhang Q
Sci China Life Sci; 2013 Apr; 56(4):335-40. PubMed ID: 23483340
[TBL] [Abstract][Full Text] [Related]
17. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence.
Houssami N; Turner R; Macaskill P; Turnbull LW; McCready DR; Tuttle TM; Vapiwala N; Solin LJ
J Clin Oncol; 2014 Feb; 32(5):392-401. PubMed ID: 24395846
[TBL] [Abstract][Full Text] [Related]
18. Underweight, Markers of Cachexia, and Mortality in Acute Myocardial Infarction: A Prospective Cohort Study of Elderly Medicare Beneficiaries.
Bucholz EM; Krumholz HA; Krumholz HM
PLoS Med; 2016 Apr; 13(4):e1001998. PubMed ID: 27093615
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
20. Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer.
Marret H; Perrotin F; Bougnoux P; Descamps P; Hubert B; Lefranc T; Le Floch O; Lansac J; Body G
Breast Cancer Res Treat; 2001 Mar; 66(1):17-23. PubMed ID: 11368406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
